IB2-ⅡA期宫颈癌患者中术前多种新辅助治疗的前瞻性、随机、对照的研究.pdfVIP

IB2．IIA期宫颈癌患者中术前多种新辅助治疗的前瞻性、随机、对照研究 英文摘要 Abstract cancerhavea survival Patientswith IB2toIIAcervical poor Object stage a to ofwhat treatmentis conducted regardless primary performed．We study demonstratewhether treatmentcouldoffersurvivalbenefitstothose neoadjuvant patients． MethodsBetweenJan2006andDec 23 with IB2toIIA 2009，1 stage patients cervicalcancerwereenrolledand toreceiveoneofthe randomlyassigned following fourtreatments：radical withatotal of alone(ArmRS)，brachytherapydosage surgery 1 tO Afollowedradical chemotherapy 5Gypoint by surgery(ArmBT)，intravenous with 5-Fu attwo—weekintervalfortwocourses 50mg／m2plus 750mg／m2 cisplatin followedradical intra-arterial withthesame IVCT)or chemotherapy by surgery(Arm astheIVCTarmfollowedradical weeksafter regimen by surgery(ArmIACT)．Two evaluationfor and underwent treatment，all responseoperability． neoadjuvant patients Thosewhowerenotamenableto receivedconcurrent surgery chemo—radiotherapy． ResultsWithamean of34．8 20 wereevaluable． follow—up months，1patients B